[go: up one dir, main page]

CN105249974A - Pressure-modulation-spectrum-technology-based noninvasive glucose detection system and method - Google Patents

Pressure-modulation-spectrum-technology-based noninvasive glucose detection system and method Download PDF

Info

Publication number
CN105249974A
CN105249974A CN201510670705.9A CN201510670705A CN105249974A CN 105249974 A CN105249974 A CN 105249974A CN 201510670705 A CN201510670705 A CN 201510670705A CN 105249974 A CN105249974 A CN 105249974A
Authority
CN
China
Prior art keywords
glucose
light
tissue
noinvasive
pressure modulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510670705.9A
Other languages
Chinese (zh)
Inventor
苏尼·斯万伯格
张�浩
林惠莺
黄静
卡塔琳娜·斯万伯格
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
South China Normal University
Original Assignee
South China Normal University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by South China Normal University filed Critical South China Normal University
Priority to CN201510670705.9A priority Critical patent/CN105249974A/en
Publication of CN105249974A publication Critical patent/CN105249974A/en
Pending legal-status Critical Current

Links

Landscapes

  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

Abstract

本发明公开了一种基于压力调制光谱技术的无创葡萄糖检测系统,包括光源、电源、压力调制器、多个探测器以及电脑,所述光源经由电源控制产生所需波段的光,所产生的光到达人体组织,所述压力调制器对人体组织进行周期性的按压,光从人体组织中反射后传输到探测器,其中光的入射位置和探测器的探测位置之间有一距离,探测器将采集到的数据发送至电脑进行处理从而提取出葡萄糖的光谱信息以及浓度信息。本发明的无创葡萄糖检测系统可使葡萄糖的吸收信号得到极大的增强,这使得葡萄糖的检测更可靠并且可以进行重复测量。

The invention discloses a non-invasive glucose detection system based on pressure modulation spectrum technology, which includes a light source, a power supply, a pressure modulator, a plurality of detectors and a computer. When the pressure modulator reaches the human tissue, the pressure modulator periodically presses the human tissue, and the light is reflected from the human tissue and then transmitted to the detector. There is a distance between the incident position of the light and the detection position of the detector, and the detector will collect The received data is sent to the computer for processing to extract the spectral information and concentration information of glucose. The non-invasive glucose detection system of the present invention can greatly enhance the glucose absorption signal, which makes the glucose detection more reliable and can perform repeated measurements.

Description

一种基于压力调制光谱技术的无创葡萄糖检测系统与方法A non-invasive glucose detection system and method based on pressure modulation spectroscopy

技术领域technical field

本发明涉及医学技术领域,特别涉及一种基于压力调制光谱技术的无创葡萄糖检测系统与方法。The invention relates to the field of medical technology, in particular to a non-invasive glucose detection system and method based on pressure modulation spectroscopy technology.

背景技术Background technique

糖尿病是一种影响全球数百万人的疾病,而且发病率还在日益上升。糖尿病患者需要通过频繁注射胰岛素来控制他们的血糖水平,而胰岛素的注射量是通过每天多次进行血液采样来决定的。这种有创检测方法通常利用一些化学添加试剂与血糖发生化学作用生成一些化学成分,而检测这些成分比直接测量葡萄糖更加容易,比如可以测量颜色的变化或氧化电流的大小。然而,有创检测不仅给患者带来了相当大的痛苦,还有可能带来一些并发症。Diabetes is a disease that affects millions of people around the world, and the incidence is increasing day by day. People with diabetes need to control their blood sugar levels with frequent insulin injections, which are determined by taking blood samples several times a day. This invasive detection method usually uses some chemical additives to chemically react with blood sugar to generate some chemical components, and detecting these components is easier than directly measuring glucose, such as measuring color changes or oxidation currents. However, invasive testing not only brings considerable pain to patients, but also may bring some complications.

近年来经过大量的研究和尝试,无创血糖浓度检测的方法已经逐步发展起来。这些无创检测方法不需要进行血液采样,不会给人体造成任何创伤。大部分的无创血糖检测方法是基于光谱技术的,主要采用近红外或中红外波段葡萄糖的吸收光谱作为检测方法。葡萄糖分子在1.59nm,2.12nm,2.27nm,2.32nm波长附近以及在9-10μm波段范围内有吸收峰值。直接吸收光谱法或基于倏逝场效应的吸收光谱法(利用可移植的传感器),光声光谱法以及拉曼光谱法已经成功应用于无创血糖浓度的检测。After a lot of research and attempts in recent years, the method of non-invasive blood glucose concentration detection has been gradually developed. These non-invasive detection methods do not require blood sampling and do not cause any trauma to the human body. Most of the non-invasive blood glucose detection methods are based on spectroscopic technology, and the absorption spectrum of glucose in the near-infrared or mid-infrared band is mainly used as the detection method. Glucose molecules have absorption peaks near the wavelengths of 1.59nm, 2.12nm, 2.27nm, 2.32nm and in the range of 9-10μm. Direct absorption spectroscopy or evanescent field-effect-based absorption spectroscopy (using implantable sensors), photoacoustic spectroscopy, and Raman spectroscopy have been successfully applied for noninvasive detection of blood glucose concentration.

利用光谱学方法对人体组织的血糖进行无创检测仍然面临着一些主要的挑战。一方面,生物组织中除了血糖外还含有很多的其它生理成分(例如水,蛋白质,脂肪等)。这些成分通常有更加显著的光的吸收特性,远远大于葡萄糖对光的吸收。另一方面,葡萄糖在血液中的含量很低,一般在30-500mg/dl范围内。Noninvasive detection of blood glucose in human tissue using spectroscopic methods still faces some major challenges. On the one hand, biological tissues contain many other physiological components (such as water, protein, fat, etc.) besides blood sugar. These components generally have more pronounced light absorption properties, far greater than that of glucose. Glucose, on the other hand, is found in very low levels in the blood, typically in the range of 30-500 mg/dl.

众所周知,气体具有较窄的吸收谱线。当对微弱气体信号进行检测时,通常采用波长或频率调制技术对具有窄带发射谱线的激光进行调制,探测气体吸收线上斜率急剧变化的信号。一般来讲,调制振幅的大小为信号半高宽数量级或更小。随后利用锁相技术对强度调制信号进行灵敏的频率或相位锁定探测,可以得到导数光谱信号。由于系统1/f噪声的影响,将信号从基态移动到高频进行探测,这样可以极大的减小噪声,提高信噪比。散射介质中的吸收光谱技术(gasinscatteringmediaabsorptionspectroscopy,GASMAS)主要用于研究散射介质(包括水果,药片,陶瓷,人体组织腔体等)的气孔或腔体内分布的气体。固体介质具有较强的宽吸收谱,而分布在固体中的气体具有微弱的窄吸收信号。因此,锁相技术可以被用来有效地把气体吸收信号从固体吸收谱中隔离出来。It is well known that gases have narrow absorption lines. When detecting weak gas signals, wavelength or frequency modulation technology is usually used to modulate the laser with a narrow-band emission line to detect the signal with a sharp change in the slope of the gas absorption line. Generally speaking, the magnitude of the modulation amplitude is on the order of the half-width of the signal or smaller. Subsequent sensitive frequency or phase-locked detection of the intensity-modulated signal using phase-locking techniques yields derivative spectral signals. Due to the influence of system 1/f noise, the signal is moved from the ground state to high frequency for detection, which can greatly reduce the noise and improve the signal-to-noise ratio. The absorption spectroscopy technique in scattering media (gasinscatteringmediaabsorptionspectroscopy, GASMAS) is mainly used to study the gas distribution in pores or cavities of scattering media (including fruits, tablets, ceramics, human tissue cavities, etc.). The solid medium has a strong broad absorption spectrum, while the gas distributed in the solid has a weak narrow absorption signal. Therefore, the phase-locking technique can be used to effectively isolate the gas absorption signal from the solid absorption spectrum.

与此相反,从较强的宽吸收谱的背景信号中隔离出较弱的宽吸收谱的目标信号,这正是组织中血糖浓度的光谱检测所要面临的问题。此时,常用的光谱调制技术不再适用。On the contrary, isolating the weak target signal with broad absorption spectrum from the strong background signal with broad absorption spectrum is exactly the problem to be faced in the spectral detection of blood glucose concentration in tissue. At this point, commonly used spectral modulation techniques are no longer applicable.

发明内容Contents of the invention

本发明的目的在于克服现有技术的缺点与不足,提供一种基于压力调制光谱技术的无创葡萄糖检测系统与方法。The purpose of the present invention is to overcome the shortcomings and deficiencies of the prior art, and provide a non-invasive glucose detection system and method based on pressure modulation spectroscopy.

本发明的目的通过如下技术方案实现:一种基于压力调制光谱技术的无创葡萄糖检测系统,包括光源1、电源2、压力调制器6、多个探测器8以及电脑9;所述光源1经由电源2控制产生所需波段的光,所产生的光传输到人体组织4,所述压力调制器6对人体组织4进行周期性的按压,从人体组织4中反射的光传输到多个探测器8,其中光的入射位置和多个探测器8的探测位置之间有一距离,多个探测器8将采集到的数据发送至电脑9进行处理从而提取出葡萄糖的光谱信息以及浓度信息。The purpose of the present invention is achieved through the following technical solutions: a non-invasive glucose detection system based on pressure modulation spectroscopy, including a light source 1, a power supply 2, a pressure modulator 6, a plurality of detectors 8 and a computer 9; 2 Controlling the generation of light in the required wavelength band, the generated light is transmitted to the human tissue 4, the pressure modulator 6 periodically presses the human tissue 4, and the light reflected from the human tissue 4 is transmitted to multiple detectors 8 , wherein there is a distance between the incident position of the light and the detection positions of the plurality of detectors 8, and the plurality of detectors 8 send the collected data to the computer 9 for processing to extract the spectral information and concentration information of glucose.

所述探测器8数量为1个时,系统中还包括一集成光纤探头5,所述集成光纤探头5由入射光纤3和多根环形排列的收集光纤7构成,所述入射光纤3和光源2连接,光通过入射光纤到达人体组织,所述收集光纤7和探测器8连接,所述收集光纤收集从人体组织反射后的光后传输给探测器8。When the number of the detector 8 is 1, an integrated optical fiber probe 5 is also included in the system, and the integrated optical fiber probe 5 is composed of an incident optical fiber 3 and a plurality of collection optical fibers 7 arranged in a ring, and the incident optical fiber 3 and the light source 2 connected, the light reaches the human tissue through the incident optical fiber, the collecting optical fiber 7 is connected to the detector 8, and the collecting optical fiber collects the light reflected from the human tissue and transmits it to the detector 8.

所述光的入射位置与探测位置之间的距离在0.5mm-10mm之间。入射位置为从光源发出的光到达人体组织上的位置,或入射光纤末端在人体组织上的所对应的位置;探测位置为在人体组织上与入射点相隔一定距离的位置,从该部分反射或散射回来的光被探测器接收,或收集光纤末端所在组织上所对应的位置。The distance between the incident position of the light and the detection position is between 0.5mm-10mm. The incident position is the position where the light emitted from the light source reaches the human tissue, or the corresponding position of the end of the incident optical fiber on the human tissue; The scattered light is received by the detector, or collected at the corresponding location on the tissue where the end of the fiber is located.

所述光源1的光波段为650nm-2500nm。选择合适的波长用于葡萄糖的测量,其中包括标准脉搏血氧仪所采用的两种波长(660nm和910nm)。利用常用脉搏血氧仪所使用的波长可以估计氧合血红蛋白和去氧血红蛋白的含量,进而精确地消除血氧变化所造成的影响。这不仅使得血糖传感器更加灵敏,而且使得血糖的测量更具有针对性。利用两种波长测量血氧,随后将测量结果输入到用于估计葡萄糖浓度的算法中。相对于其他可能的方法,此方法可以得到更高的精度。The light waveband of the light source 1 is 650nm-2500nm. Appropriate wavelengths were chosen for glucose measurement, including the two wavelengths (660nm and 910nm) used by standard pulse oximeters. Oxygenated and deoxygenated hemoglobin can be estimated using the wavelengths used by common pulse oximeters, thereby accurately canceling the effects of changes in blood oxygenation. This not only makes the blood glucose sensor more sensitive, but also makes the measurement of blood glucose more targeted. Blood oxygen is measured at two wavelengths, which are then fed into an algorithm for estimating glucose concentrations. This method can achieve higher accuracy than other possible methods.

所述光源1为发光二极管、二极管激光器、或卤钨灯与带通滤波片的组合。The light source 1 is a combination of light-emitting diodes, diode lasers, or tungsten-halogen lamps and band-pass filters.

所述对人体组织4进行的周期性的按压通过将电动马达或磁性器件安装到手指夹或耳垂夹或一能够作用于身体其他柔软部分的设备之上实现。The periodic pressing of the human tissue 4 is realized by installing an electric motor or a magnetic device on a finger clip or an earlobe clip or a device capable of acting on other soft parts of the body.

所述检测系统还包括一可移植的胰岛素注射装置,所述胰岛素注射装置根据测量出的葡萄糖浓度指令释放适量的胰岛素。而且该注射装置中可以存放足量的胰岛素进行使用。The detection system also includes an implantable insulin injection device commanded to release an appropriate amount of insulin based on the measured glucose concentration. Moreover, a sufficient amount of insulin can be stored in the injection device for use.

本发明的另一目的通过如下技术方案实现:一种基于压力调制光谱技术的无创葡萄糖检测方法,利用光源产生的光探测人体组织的反射光谱,通过周期性的压缩人体组织来消除背景光谱信号,并在压缩/心跳暂停期间和非压缩/心跳期间对反射光谱间歇性地进行记录,将所述记录依次进行求平均值、差分和比例的计算,使得测量的光谱不再取决于入射光强度的变化,最后再使用标准拟合方法或多变量分析方法进行分析并提取出葡萄糖的光谱信息。Another object of the present invention is achieved through the following technical solutions: a non-invasive glucose detection method based on pressure modulation spectroscopy technology, using the light generated by the light source to detect the reflection spectrum of human tissue, and periodically compressing human tissue to eliminate background spectral signals, And the reflectance spectrum is recorded intermittently during compression/heartbeat pause and non-compression/heartbeat period, and the records are sequentially calculated for averaging, difference and ratio, so that the measured spectrum no longer depends on the intensity of incident light Finally, use the standard fitting method or multivariate analysis method to analyze and extract the spectral information of glucose.

本发明与现有技术相比,具有如下优点和有益效果:Compared with the prior art, the present invention has the following advantages and beneficial effects:

1、本发明通过周期性压缩人体组织的方法使葡萄糖的吸收信号得到极大的增强,这使得葡萄糖的检测更可靠并且可以进行重复测量。1. The present invention greatly enhances the absorption signal of glucose by periodically compressing human tissue, which makes the detection of glucose more reliable and can be repeated.

2、本发明的光源所选择的光波长可以估计氧合血红蛋白和去氧血红蛋白的含量,进而精确地消除血氧变化所造成的影响。这不仅使得血糖传感器更加灵敏,而且使得血糖的测量更具有针对性。2. The light wavelength selected by the light source of the present invention can estimate the content of oxygenated hemoglobin and deoxygenated hemoglobin, and then accurately eliminate the influence caused by the change of blood oxygen. This not only makes the blood glucose sensor more sensitive, but also makes the measurement of blood glucose more targeted.

附图说明Description of drawings

图1为本发明所述的基于压力调制光谱技术的无创葡萄糖检测系统的示意图;1 is a schematic diagram of a non-invasive glucose detection system based on pressure modulation spectroscopy according to the present invention;

图2为图1所述系统的光纤探头结构图;Fig. 2 is the optical fiber probe structural diagram of system described in Fig. 1;

图3为本发明实施例中基于多个探测器的探测装置结构图;3 is a structural diagram of a detection device based on multiple detectors in an embodiment of the present invention;

图4为本发明实施例中所采用的手指夹传感器示意图;Fig. 4 is the schematic diagram of the finger clip sensor adopted in the embodiment of the present invention;

图5为本发明实施例中组织的液态组分和非液态组分所产生的吸收光谱图;Fig. 5 is the absorption spectrogram produced by the liquid component and the non-liquid component of the tissue in the embodiment of the present invention;

图6为本发明实施例中提取出来的葡萄糖的吸收光谱图。Fig. 6 is an absorption spectrum diagram of glucose extracted in the embodiment of the present invention.

具体实施方式detailed description

下面结合实施例及附图对本发明作进一步详细的描述,但本发明的实施方式不限于此。The present invention will be further described in detail below in conjunction with the embodiments and the accompanying drawings, but the embodiments of the present invention are not limited thereto.

一种基于压力调制光谱技术的无创葡萄糖检测系统,如图1所示包括光源1、电源2、入射光纤3、集成光纤探头5、压力调制器6、收集光纤7、探测器8以及电脑9,所述光源1经由电源2控制产生所需波段的光,所产生的光通过入射光纤3传输到达人体组织4,所述压力调制器6控制集成光纤探头5对人体组织4进行周期性的按压,光从人体组织4中反射后被集成光纤探头5接收并由收集光纤7传输到探测器8,探测器8将采集到的数据发送至电脑9进行处理从而提取出葡萄糖的光谱信息以及浓度信息。A noninvasive glucose detection system based on pressure modulation spectroscopy technology, as shown in Figure 1, includes a light source 1, a power supply 2, an incident optical fiber 3, an integrated optical fiber probe 5, a pressure modulator 6, a collection optical fiber 7, a detector 8 and a computer 9, The light source 1 is controlled by the power supply 2 to generate light in the required band, and the generated light is transmitted to the human tissue 4 through the incident optical fiber 3, and the pressure modulator 6 controls the integrated optical fiber probe 5 to periodically press the human tissue 4, After the light is reflected from the human body tissue 4, it is received by the integrated optical fiber probe 5 and transmitted to the detector 8 by the collecting optical fiber 7. The detector 8 sends the collected data to the computer 9 for processing to extract the spectral information and concentration information of glucose.

所述光源1的光波段为650nm-2500nm。选择合适的波长用于葡萄糖的测量,其中包括标准脉搏血氧仪所采用的两种波长。利用常用脉搏血氧仪所使用的波长可以估计氧合血红蛋白和去氧血红蛋白的含量,进而精确地消除血氧变化所造成的影响。这不仅使得血糖传感器更加灵敏,而且使得血糖的测量更具有针对性。利用两种波长测量血氧,随后将测量结果输入到用于估计葡萄糖浓度的算法中。相对于其他可能的方法,此方法可以得到更高的精度。The light waveband of the light source 1 is 650nm-2500nm. Select the appropriate wavelength for glucose measurement, including the two wavelengths used by standard pulse oximeters. Oxygenated and deoxygenated hemoglobin can be estimated using the wavelengths used by common pulse oximeters, thereby accurately canceling the effects of changes in blood oxygenation. This not only makes the blood glucose sensor more sensitive, but also makes the measurement of blood glucose more targeted. Blood oxygen is measured at two wavelengths, which are then fed into an algorithm for estimating glucose concentrations. This method can achieve higher accuracy than other possible methods.

所述光源1为发光二极管、二极管激光器、或卤钨灯与带通滤波片的组合。用于检测葡萄糖浓度的周期性调制信号,可以通过类似于脉搏血氧仪所使用的方法进行估计。The light source 1 is a combination of light-emitting diodes, diode lasers, or tungsten-halogen lamps and band-pass filters. The periodically modulated signal used to detect glucose concentration can be estimated by a method similar to that used by pulse oximeters.

所述集成光纤探头5的入射位置与探测位置之间有一距离。基于压力调制光谱技术的无创葡萄糖检测系统,有两种探测方式。方式一是采用一个集成光纤探头,该探头由一根入射光纤和多根环形排列的收集光纤构成。入射光纤和光源连接,收集光纤和一个探测器连接。另一种探测方式是采用一个集成探测装置,该装置包括一个光源和多个探测器,其中探测器在光源周围呈环形方式排列。这两种方式的共同点都采用后向散射探测方式,并且光的入射位置和探测位置间有一距离。入射位置为从光源发出的光到达人体组织上的位置,或入射光纤末端在人体组织上的所对应的位置;探测位置为在人体组织上与入射点相隔一定距离的位置,从该部分反射或散射回来的光被探测器接收,或收集光纤末端所在组织上所对应的位置。There is a distance between the incident position of the integrated optical fiber probe 5 and the detection position. There are two detection methods for the non-invasive glucose detection system based on pressure modulation spectroscopy. The first way is to use an integrated optical fiber probe, which is composed of an incident optical fiber and multiple collection optical fibers arranged in a ring. The incident fiber is connected to the light source, and the collection fiber is connected to a detector. Another detection method is to use an integrated detection device, which includes a light source and multiple detectors, wherein the detectors are arranged in a ring around the light source. The common point of these two methods is the backscattering detection method, and there is a distance between the incident position of light and the detection position. The incident position is the position where the light emitted from the light source reaches the human tissue, or the corresponding position of the end of the incident optical fiber on the human tissue; The scattered light is received by the detector, or collected at the corresponding location on the tissue where the end of the fiber is located.

所述探测器8数量为1个时,系统中还包括一集成光纤探头5,所述集成光纤探头5由入射光纤3和多根环形排列的收集光纤7构成,入射光纤3和光源2连接,收集光纤7和探测器8连接。When the number of the detector 8 is 1, an integrated optical fiber probe 5 is also included in the system, and the integrated optical fiber probe 5 is composed of an incident optical fiber 3 and a plurality of collection optical fibers 7 arranged in a ring, and the incident optical fiber 3 is connected to the light source 2, The collecting optical fiber 7 is connected with the detector 8.

如图2所示,该光纤探头由一根入射光纤和多根收集光纤构成。考虑到水对光有较强的吸收,而且确保探测器能够接收到最大量的漫反射光,大多数情况下合适距离的分离是必需的。图2(a)为压力调制前的探测系统,图2(b)为压力调制Δx距离后的探测系统。图2(c)为光纤探头的剖面图。As shown in Figure 2, the fiber optic probe consists of an incident fiber and multiple collection fibers. Considering that water has a strong absorption of light, and to ensure that the detector can receive the maximum amount of diffuse reflected light, in most cases a suitable separation distance is necessary. Figure 2(a) is the detection system before pressure modulation, and Figure 2(b) is the detection system after pressure modulation Δx distance. Figure 2(c) is a cross-sectional view of the fiber optic probe.

所述入射位置与探测位置之间的距离在0.5-10mm之间。如图3所示,是在采用一根入射光纤和多个探测器的情况下,压力调制运作的探测装置。该探测装置将入射光纤和多个探测器集成在一起,所有探测器以环形方式排列,并且光纤和探测器之间有一距离。其中图3(a)是压力调制前的探测系统,图3(b)是压力调制Δx距离后的探测系统,图3(c)是探测装置的剖面图。The distance between the incident position and the detection position is between 0.5-10mm. As shown in Figure 3, it is a detection device with pressure modulation operation under the condition of using one incident optical fiber and multiple detectors. The detection device integrates the incident optical fiber and multiple detectors, all the detectors are arranged in a circular manner, and there is a distance between the optical fiber and the detectors. Figure 3(a) is the detection system before pressure modulation, Figure 3(b) is the detection system after pressure modulation Δx distance, and Figure 3(c) is a cross-sectional view of the detection device.

所述检测系统还包括一可移植的胰岛素注射装置10,所述胰岛素注射装置根据测量出的葡萄糖浓度指令释放适量的胰岛素。而且该注射装置中的胰岛素剂量应该足够使用一段时间。The detection system also includes an implantable insulin injection device 10 which commands the release of an appropriate amount of insulin based on the measured glucose concentration. And the dose of insulin in the injection device should be sufficient for a period of time.

一种基于压力调制光谱技术的无创葡萄糖检测方法,利用光源产生的光探测人体组织的反射光谱,通过周期性的压缩人体组织来消除背景光谱信号,并在压缩/心跳暂停期间和非压缩/心跳期间对反射光谱间歇性地进行记录,将所述记录依次进行求平均值、差分和比例的计算,使得测量的光谱不再取决于入射光强度的变化,最后再使用标准拟合方法或多变量分析方法进行分析并提取出葡萄糖的光谱信息。A non-invasive glucose detection method based on pressure-modulated spectroscopy technology, which uses light generated by a light source to detect the reflection spectrum of human tissue, and periodically compresses human tissue to eliminate background spectral signals, and during compression/heartbeat pauses and non-compression/heartbeat The reflectance spectrum is recorded intermittently during this period, and the records are sequentially calculated for averaging, difference and ratio, so that the measured spectrum no longer depends on the change of the incident light intensity, and finally the standard fitting method or multivariate The analytical method is used to analyze and extract the spectral information of glucose.

所述对人体组织4进行的周期性的按压通过将电动马达或磁性器件安装到手指夹或耳垂夹或一能够作用于身体其他柔软部分的设备之上实现。如图4所示,是一个手指夹11(或耳垂夹)传感装置。入射光纤12和探测器13集成到手指夹内,可以直接与手指14相互接触。由马达17驱动促动器16的升降来实现压力的调制。控制器18通过一个连接器15和手指夹相连,不仅可以控制马达的驱动19进行压力调制,同时还可以控制光源的开关20,以及控制与电脑22相连的数据采集卡21进行数据的采集。The periodic pressing of the human tissue 4 is realized by installing an electric motor or a magnetic device on a finger clip or an earlobe clip or a device capable of acting on other soft parts of the body. As shown in FIG. 4 , it is a finger clip 11 (or earlobe clip) sensing device. The incident optical fiber 12 and the detector 13 are integrated into the finger clip, and can be in direct contact with the finger 14 . The motor 17 drives the lift of the actuator 16 to achieve pressure modulation. The controller 18 is connected to the finger clip through a connector 15, which can not only control the motor drive 19 for pressure modulation, but also control the switch 20 of the light source, and control the data acquisition card 21 connected to the computer 22 to collect data.

如图5所示,描述了组织的液态组分和非液态组分所产生的吸收光谱,其中液态组分的吸收光谱可以被调制。调制部分的光谱形状和液体组分的光谱是相同的。图中A0为压力调制前的光谱,A1为压力调制后的光谱。As shown in Fig. 5, the absorption spectra produced by the liquid components and the non-liquid components of the tissue are described, wherein the absorption spectra of the liquid components can be modulated. The spectral shape of the modulated part is the same as that of the liquid component. A0 in the figure is the spectrum before pressure modulation, and A1 is the spectrum after pressure modulation.

如图6所示,其中图6a描述的光谱仅仅取决于调制,其中ΔA=A1-A0。这些光谱的差别很大程度上来自于葡萄糖的吸收,因为非液体组分产生的偏移已经消除。图6a的光谱中包含了氧合血红蛋白和去氧血红蛋白的信息,通常可以利用脉搏血氧仪在相应的波长处得到它们的光谱信息。图6b描述了分离出来的葡萄糖的光谱,利用多变量统计分析技术可以从图6a中的光谱中把葡萄糖的光谱分离出来的。As shown in Figure 6, where the spectrum depicted in Figure 6a depends only on the modulation, where ΔA=A1-A0. The difference in these spectra is largely due to the absorption of glucose, since the shift due to non-liquid components has been removed. The spectrum in Figure 6a contains the information of oxyhemoglobin and deoxygenated hemoglobin, and their spectral information can usually be obtained at corresponding wavelengths by using a pulse oximeter. Figure 6b depicts the spectrum of isolated glucose, which can be separated from the spectrum in Figure 6a using multivariate statistical analysis techniques.

考虑到光的入射位置,探测位置,探测方式,组织的压缩程度以及调制频率这些因素可能带来的影响,该装置应该通过实验进行优化,以便产生最优的调制,得到最好的葡萄糖信号。除了可以利用周期性的压缩实现调制外,周期性的拉伸也可以产生有效的调制。Considering the possible effects of light incident position, detection position, detection method, tissue compression degree and modulation frequency, the device should be optimized through experiments in order to produce the optimal modulation and obtain the best glucose signal. In addition to the periodic compression that can be used to achieve modulation, the periodic stretch can also produce effective modulation.

周期性的组织压缩可以利用一个电动马达或一个磁性器件来实现。这个器件可以安装到一个手指夹上,一个耳垂夹上(可穿戴设备)或者一个可以作用于身体其他柔软部分的设备上。利用一个集成的小直径光纤光学传输/探测探头,可以通过周期性的上下移动探头(几毫米左右)来方便地进行调制。如上所述,在测量开始时,可以将一个传感器作用于人体,或通过连续地穿戴进行周期性的压缩。毫无疑问,调制频率必须保持足够低以使得组织在压缩间隙可以重新被液态组织填充。尽管如此,依赖于1/f的背景噪声仍然可以被降低。Periodic tissue compression can be achieved using an electric motor or a magnetic device. The device can be attached to a finger clip, an earlobe clip (wearable device) or a device that acts on other soft parts of the body. Utilizing an integrated small-diameter fiber optic transmission/detection probe, modulation is conveniently performed by periodically moving the probe up and down (a few millimeters or so). As mentioned above, a sensor can be applied to the body at the beginning of the measurement, or periodically compressed by continuous wear. Of course, the modulation frequency must be kept low enough so that the tissue can be refilled with liquid tissue in the compressed gap. Nevertheless, background noise can still be reduced depending on 1/f.

脉搏血氧仪利用心脏的跳动进行信号的调制。一般采用两种波长的光源(通常为LED)进行透射式测量,波长分别为位于等吸收点(808nm)附近的红色光(660nm)和近红外光(910nm)。氧合血红蛋白在660nm的吸收比去氧血红蛋白的少,在910nm的吸收比氧合血红蛋白的多。心脏跳动的调制产生了周期性的波形信号。通过记录两个波长位置的体积描记波形,可以计算出动脉血中的血氧饱和度。同样的,本发明也采用心脏跳动的调制去消除非血液组织成分所造成的强烈的背景信号。但是,应该选择合适的测量波长,以使得与葡萄糖浓度相关的信号可以提取出来。所选的波长应该包括葡萄糖的吸收峰。通过对葡萄糖最佳灵敏度处的脉搏强度进行记录,可以构建一个脉搏强度函数。另外,可以通过有创检测的结果进行校准。Pulse oximeters use the beating of the heart to modulate the signal. Generally, light sources of two wavelengths (usually LED) are used for transmission measurement, the wavelengths are red light (660nm) and near-infrared light (910nm) near the isosbestic point (808nm). Oxyhemoglobin absorbs less at 660 nm than deoxyhemoglobin and absorbs more at 910 nm than oxyhemoglobin. The modulation of the beating heart produces a periodic waveform signal. By recording the plethysmographic waveform at two wavelength positions, the oxygen saturation in arterial blood can be calculated. Likewise, the present invention also uses modulation of heart beats to eliminate strong background signals caused by non-blood tissue components. However, an appropriate measurement wavelength should be chosen so that the signal related to the glucose concentration can be extracted. The selected wavelength should include the absorption peak of glucose. By recording the pulse intensity at the point of optimal glucose sensitivity, a pulse intensity function can be constructed. Alternatively, calibration can be performed through the results of invasive testing.

利用常用脉搏血氧仪所使用的波长可以估计氧合血红蛋白和去氧血红蛋白的含量,进而精确地消除血氧变化所造成的影响。这不仅使得血糖传感器更加灵敏,而且使得血糖的测量更具有针对性。Oxygenated and deoxygenated hemoglobin can be estimated using the wavelengths used by common pulse oximeters, thereby accurately canceling the effects of changes in blood oxygenation. This not only makes the blood glucose sensor more sensitive, but also makes the measurement of blood glucose more targeted.

实际上,当使用机械调制时,采用类似于标准脉搏血氧仪所采取的方法,通过比较在两个或更多波长位置记录的体积描记调制信号波形,可以提取出葡萄糖的信号。Indeed, when mechanical modulation is used, the glucose signal can be extracted by comparing the plethysmographic modulated signal waveforms recorded at two or more wavelength positions, in an approach similar to that taken by standard pulse oximeters.

相对于其它主要组织成分,葡萄糖信号被认为具有特异性。通过外部机械调制和心跳调制的结合,可以在两个不同调制频率的倍频处将有用的信息提取出来,进而得到增强的葡萄糖信号。Glucose signaling is thought to be specific relative to other major tissue components. Through the combination of external mechanical modulation and heartbeat modulation, useful information can be extracted at the double frequency of two different modulation frequencies, and then an enhanced glucose signal can be obtained.

值得提出的是,虽然组织的吸收(在具有较低的穿透深度的情况时,采用漫反射探测方式)被作为首选方法,考虑到拉曼光谱对葡萄糖的拉曼跃迁非常灵敏,拉曼光谱法也可以用于压力调制葡萄糖光谱测量中。此时,一个固定频率的激光光源将用来激发拉曼跃迁。It is worth mentioning that although tissue absorption (diffuse reflectance detection in the case of lower penetration depths) is the preferred method, given that Raman spectroscopy is very sensitive to the Raman transition of glucose, Raman spectroscopy The method can also be used in the measurement of pressure-modulated glucose spectroscopy. At this point, a laser source with a fixed frequency will be used to excite the Raman transition.

上述实施例为本发明较佳的实施方式,但本发明的实施方式并不受上述实施例的限制,其他的任何未背离本发明的精神实质与原理下所作的改变、修饰、替代、组合、简化,均应为等效的置换方式,都包含在本发明的保护范围之内。The above-mentioned embodiment is a preferred embodiment of the present invention, but the embodiment of the present invention is not limited by the above-mentioned embodiment, and any other changes, modifications, substitutions, combinations, Simplifications should be equivalent replacement methods, and all are included in the protection scope of the present invention.

Claims (9)

1. the noinvasive glucose detection systems based on pressure modulation spectral technique, it is characterized in that: comprise power supply (1), light source (2), pressure modulator (6), multiple detector (8) and computer (9), described light source (2) controls via power supply (1) light producing required wave band, the light produced arrives tissue (4), described pressure modulator (6) periodically presses tissue (4), light is transferred to multiple detector (8) after reflecting from tissue (4), wherein there is a distance between the incoming position of light and the detecting location of multiple detector (8), the data collected are sent to computer (9) and carry out processing thus the spectral information and the concentration information that extract glucose by multiple detector (8).
2. the noinvasive glucose detection systems based on pressure modulation spectral technique according to claim 1, it is characterized in that: when described detector (8) quantity is 1, integrated optical fiber probe (5) is also comprised in system, described integrated optical fiber probe (5) is made up of the collection optical fiber (7) of incident optical (3) and many annular array, described incident optical (3) is connected with light source (2), light arrives tissue by incident optical, described collection optical fiber (7) is connected with detector (8), described collection optical fiber is collected and be transferred to detector (8) after the light after tissue reflection.
3. the noinvasive glucose detection systems based on pressure modulation spectral technique according to claim 1 and 2, is characterized in that: the distance between the incoming position of described light and detecting location is 0.5mm-10mm.
4. the noinvasive glucose detection systems based on pressure modulation spectral technique according to claim 1 and 2, is characterized in that: the optical band of described light source (1) is 650nm-2500nm.
5. the noinvasive glucose detection systems based on pressure modulation spectral technique according to claim 1 and 2, is characterized in that: the combination that described light source (1) is halogen tungsten lamp and band pass filter, light emitting diode or diode laser.
6. the noinvasive glucose detection systems based on pressure modulation spectral technique according to claim 1 and 2, is characterized in that: described tissue (4) is carried out periodically to realize pressed through electro-motor or magnetic device.
7. the noinvasive glucose detection systems based on pressure modulation spectral technique according to claim 1 and 2, is characterized in that: described electro-motor or magnetic device are installed to finger clamp or ear lobe clamp or can act on the equipment of other softs of health.
8. the noinvasive glucose detection systems based on pressure modulation spectral technique according to claim 1 and 2, it is characterized in that: also comprise a transplantable insulin injection device (10), described insulin injection device (10) discharges appropriate insulin according to the concentration of glucose instruction of measuring.
9. the noinvasive glucose sensing approach based on pressure modulation spectral technique, it is characterized in that: the reflectance spectrum of the optical detection tissue utilizing light source to produce, background spectrum signal is eliminated by periodically compressing tissue, and between compression/heart beating interval and uncompressed/heart beat period, intermittently record is carried out to reflectance spectrum, described record is averaged successively, the calculating of difference and ratio, the spectrum measured is made no longer to depend on the change of incident intensity, finally re-use standard fit method or multivariable technique carries out analyzing and extracts the spectral information of glucose.
CN201510670705.9A 2015-10-15 2015-10-15 Pressure-modulation-spectrum-technology-based noninvasive glucose detection system and method Pending CN105249974A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510670705.9A CN105249974A (en) 2015-10-15 2015-10-15 Pressure-modulation-spectrum-technology-based noninvasive glucose detection system and method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510670705.9A CN105249974A (en) 2015-10-15 2015-10-15 Pressure-modulation-spectrum-technology-based noninvasive glucose detection system and method

Publications (1)

Publication Number Publication Date
CN105249974A true CN105249974A (en) 2016-01-20

Family

ID=55090141

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510670705.9A Pending CN105249974A (en) 2015-10-15 2015-10-15 Pressure-modulation-spectrum-technology-based noninvasive glucose detection system and method

Country Status (1)

Country Link
CN (1) CN105249974A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109770916A (en) * 2019-01-22 2019-05-21 曾曹宁 Non-invasive blood glucose meter Raman light acquisition method, collector and blood glucose meter
CN109984725A (en) * 2017-12-29 2019-07-09 天津先阳科技发展有限公司 Contact pressure disturbance restraining method, device and measurement method in diffusing reflection measurement
CN111449623A (en) * 2020-03-26 2020-07-28 天津大学 Subdiffuse tissue domain spatially resolved optical measurement system for rapid diagnosis of cervical cancer
CN114081481A (en) * 2021-11-16 2022-02-25 武汉联影智融医疗科技有限公司 Blood glucose signal acquisition device, blood glucose concentration detection device and detection system
CN114099847A (en) * 2021-11-05 2022-03-01 长电科技管理有限公司 Blood sugar control cavity packaging device and control method thereof

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5178142A (en) * 1989-05-23 1993-01-12 Vivascan Corporation Electromagnetic method and apparatus to measure constituents of human or animal tissue
US5529755A (en) * 1994-02-22 1996-06-25 Minolta Co., Ltd. Apparatus for measuring a glucose concentration
CN1184936A (en) * 1996-11-26 1998-06-17 松下电工株式会社 Device for non-invasive determination of glucose concn. in blood of subject
CN1418072A (en) * 2000-03-15 2003-05-14 奥森斯有限公司 Probe for use in non-invasive measurements of blood related parameters
US20030204133A1 (en) * 2002-04-26 2003-10-30 Hannu Harjunmaa Non-invasive substance concentration measurement using and optical bridge
CN1550209A (en) * 2003-03-19 2004-12-01 三星电子株式会社 Method and apparatus for noninvasively measuring a concentration of a blood component
CN1798520A (en) * 2003-06-03 2006-07-05 奥森斯有限公司 Method and system for use in non-invasive optical measurements of blood parameters
CN101605493A (en) * 2006-09-25 2009-12-16 格鲁夫设备有限公司 The optical bridge system of three diodes
CN103149177A (en) * 2013-01-14 2013-06-12 天津先阳科技发展有限公司 Device and method for detecting biological tissue of pressure modulation near infrared spectrum
CN104395732A (en) * 2012-04-06 2015-03-04 格罗夫器械股份有限公司 Noninvasive measurement of analyte concentration using a fiberless transflectance probe

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5178142A (en) * 1989-05-23 1993-01-12 Vivascan Corporation Electromagnetic method and apparatus to measure constituents of human or animal tissue
US5529755A (en) * 1994-02-22 1996-06-25 Minolta Co., Ltd. Apparatus for measuring a glucose concentration
CN1184936A (en) * 1996-11-26 1998-06-17 松下电工株式会社 Device for non-invasive determination of glucose concn. in blood of subject
CN1418072A (en) * 2000-03-15 2003-05-14 奥森斯有限公司 Probe for use in non-invasive measurements of blood related parameters
US20030204133A1 (en) * 2002-04-26 2003-10-30 Hannu Harjunmaa Non-invasive substance concentration measurement using and optical bridge
CN1550209A (en) * 2003-03-19 2004-12-01 三星电子株式会社 Method and apparatus for noninvasively measuring a concentration of a blood component
CN1798520A (en) * 2003-06-03 2006-07-05 奥森斯有限公司 Method and system for use in non-invasive optical measurements of blood parameters
CN101605493A (en) * 2006-09-25 2009-12-16 格鲁夫设备有限公司 The optical bridge system of three diodes
CN104395732A (en) * 2012-04-06 2015-03-04 格罗夫器械股份有限公司 Noninvasive measurement of analyte concentration using a fiberless transflectance probe
CN103149177A (en) * 2013-01-14 2013-06-12 天津先阳科技发展有限公司 Device and method for detecting biological tissue of pressure modulation near infrared spectrum

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109984725A (en) * 2017-12-29 2019-07-09 天津先阳科技发展有限公司 Contact pressure disturbance restraining method, device and measurement method in diffusing reflection measurement
CN109984725B (en) * 2017-12-29 2022-07-12 天津先阳科技发展有限公司 Contact pressure interference suppression method and device in diffuse reflection measurement and measurement method
CN109770916A (en) * 2019-01-22 2019-05-21 曾曹宁 Non-invasive blood glucose meter Raman light acquisition method, collector and blood glucose meter
CN111449623A (en) * 2020-03-26 2020-07-28 天津大学 Subdiffuse tissue domain spatially resolved optical measurement system for rapid diagnosis of cervical cancer
CN114099847A (en) * 2021-11-05 2022-03-01 长电科技管理有限公司 Blood sugar control cavity packaging device and control method thereof
CN114081481A (en) * 2021-11-16 2022-02-25 武汉联影智融医疗科技有限公司 Blood glucose signal acquisition device, blood glucose concentration detection device and detection system
CN114081481B (en) * 2021-11-16 2024-05-14 武汉联影智融医疗科技有限公司 Blood glucose concentration detection device and detection system

Similar Documents

Publication Publication Date Title
US9949675B2 (en) Noninvasive blood measurement platform
US11147482B2 (en) Method and system for non-invasive blood glucose measurement using signal change of the non-glucose components induced by the presence of glucose
US7254432B2 (en) Method and device for non-invasive measurements of blood parameters
US9149216B2 (en) Photoplethysmography device and method
CA2441017C (en) Method and apparatus for improving the accuracy of noninvasive hematocrit measurements
EP2219513B1 (en) Pulse oximetry method
ES2311028T3 (en) METHOD FOR PROCESSING A SIGNAL AND DEVICE TO IMPROVE THE SIGNAL-NOISE RELATIONSHIP.
JP6467417B2 (en) System and method for extracting physiological information from remotely detected electromagnetic radiation
US20110082355A1 (en) Photoplethysmography device and method
JP2005516642A6 (en) Signal processing method and apparatus for improving signal-to-noise ratio
CN105249974A (en) Pressure-modulation-spectrum-technology-based noninvasive glucose detection system and method
JPH10501995A (en) Self-luminous non-invasive infrared spectrophotometer
JPH07136152A (en) Method and device for uninvasively measuring concentration of blood component of animal
JP2007528276A (en) Motion artifact removal of pulse oximeter using near infrared absorption by water
JP4405469B2 (en) Biological information measuring device
WO2021040878A1 (en) Non-invasive glucose monitoring by raman spectroscopy
US8126527B2 (en) Method and system for determining the contribution of hemoglobin and myoglobin to in vivo optical spectra
JPH07132120A (en) Nonaggressive measuring method and device of specimen concentration using discontinuous emission
EP0623308A1 (en) Method for non-invasive measurement of concentration of constituents in blood
WO2019208561A1 (en) Blood component in-blood concentration measurement method, in-blood concentration measurement device and program
CN209770383U (en) Optical device for detecting glucose signal of tissue fluid in body
Bachir Diffuse transmittance visible spectroscopy using smartphone flashlight for photoplethysmography and vital signs measurements
WO2022115876A1 (en) Selectable energy modes for blood and tissue oxygenation measurement

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20160120

RJ01 Rejection of invention patent application after publication